Log In
Print this Print this

Oral octreotide

  Manage Alerts
Collapse Summary General Information
Company Aegis Therapeutics LLC
DescriptionOral formulation of a somatostatin mimic
Molecular Target
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today